ECRG4 and neoplasm: Taken together, C2orf40, as a tumor suppressor gene, could inhibit the migration ability of NPC cells and enhance the sensitivity of NPC cells to chemotherapy and radiotherapy through inhibiting HRR and the PI3K/Akt/mTOR signaling pathway.